Claims
- 1. A method for treating a person suffering from glaucoma or ocular hypertension which comprises, administering at least one glutamate antagonist and at least one intraocular pressure-lowering agent.
- 2. The method of claim 1 wherein the glutamate antagonist has the structure:
- 3. The method of claim 1 wherein the glutamate antagonist in memantine.
- 4. The method of claim 1 wherein the IOP-lowering agent is selected from the group consisting of miotics, α and α/β adrenergic agonists, beta-blockers, prostaglandins, and carbonic anhydrase inhibitors.
- 5. The method of claim 2 wherein the glutamate antagonist is eliprodil.
- 6. The method of claim 4 wherein the IOP-lowering agent is betaxolol or S-betaxolol.
- 7. The method of claim 4 wherein the IOP-lowering agent is brimonidine.
- 8. The method of claim 4 wherein the IOP-lowering agent is latanoprost.
- 9. The method of claim 4 wherein the IOP-lowering agent is travoprost.
- 10. The method of claim 4 wherein the IOP-lowering agent is timolol.
- 11. A composition comprising a glutamate antagonist and an IOP-lowering agent.
Parent Case Info
[0001] This case is a continuation in part of U.S. Ser. No. 08/919,882, filed Aug. 28, 1997, which is a continuation of U.S. Ser. No. 08/560,055, filed Nov. 17, 1995.
Continuations (1)
|
Number |
Date |
Country |
Parent |
08560055 |
Nov 1995 |
US |
Child |
08919882 |
Aug 1997 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
08919882 |
Aug 1997 |
US |
Child |
09267966 |
Mar 1999 |
US |